Dexcom stock stock recovered Friday after the diabetes devices maker missed fourth-quarter profit expectations.

The quarter reflected steady revenue growth but underscored challenges in profit conversion, as seen in declining operating ...

Sales: The California-based device maker is pinning its hopes on Stelo, its recently launched device for adults aged 18 and ...

Medical device company DexCom (NASDAQ:DXCM) reported Q4 CY2024 results topping the market’s revenue expectations, with sales ...

Today, Benzinga's options scanner identified 8 options transactions for DexCom. This is an unusual occurrence. The sentiment ...

Dexcom (Nadsaq:DXCM) shares fell after hours today on fourth-quarter results that came in mixed compared to the consensus forecast.

DexCom projects 2025 revenue of $4.6 billion, representing 14% growth. This forecast assumes strong demand for CGM systems, expanded reimbursement coverage, and a second-half launch of a 15-day G7 ...

Glucose Market Technological advancements and rising awareness in diabetes management are driving growth in the glucose market, enhancing a ...

Much progress has been made in diabetes technology over the past decade. Continuous glucose monitoring has achieved high accuracy and reliability, resulting ...

Metro Phoenix is home to a plethora of industrial manufacturing. Did you know that these 10 unique products are made in Arizona factories?

Request To Download Free Sample of This Strategic Report @ Highlighted with 26 tables and 58 figures, this 126-page report North America Connected Healthcare Device Market 2023-2033 by Product ...